Afrezza and Alemtuzumab

• Generic Name: insulin inhalation, rapid acting
• Dosage Forms: inhalation powder, metered
• Other Brand Names: Afrezza, Exubera, Exubera, EXUBERA Combination Pack 12, EXUBERA Combination Pack 15, EXUBERA Kit, Afrezza 4 unit- 8 unit, Afrezza 8 unit- 12 unit, Afrezza Titration Pack

Afrezza (insulin inhalation) is a rapid-acting form of human insulin that is inhaled through the mouth. Insulin is a hormone that works by lowering levels of glucose (sugar) in the blood. Afrezza inhalation is a fast-acting insulin that starts to work about 15 minutes after inhalation, peaks in about 1 hour, and keeps working for 2 to 4 hours.

Afrezza inhalation is used to improve blood sugar control in adults with diabetes mellitus.

If you have type 1 diabetes, you will also need to use a long-acting injectable insulin.

If you have type 2 diabetes, Afrezza may be the only medicine you need to control your blood sugar. However, your doctor may prescribe a long-acting injectable insulin or a diabetes medicine you take by mouth.

• Generic Name: alemtuzumab
• Dosage Forms: n.a.
• Other Brand Names: Campath, Lemtrada

Alemtuzumab is used to treat chronic B-cell lymphocytic leukemia.

Alemtuzumab is also used to treat relapsing forms of multiple sclerosis in adults (including active secondary progressive disease).

Alemtuzumab will not cure MS, but it can make relapses occur less often. Alemtuzumab is not for use in treating clinically isolated syndrome.

Lemtrada is available only from a certified pharmacy under a special program.

Alemtuzumab may also be used for purposes not listed in this medication guide.